<DOC>
	<DOCNO>NCT00037141</DOCNO>
	<brief_summary>Multi-center , prospective randomize dose safety research study . A maximum 150 men enrol study . Qualifying patient receive one three possible dos study drug . Symptoms evaluate treatment , 1-week , 1-month , 3-months , 6-months follow treatment .</brief_summary>
	<brief_title>Safety/Tolerability Study Alcohol Injection Treatment BPH ( Enlarged Prostate )</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Prostatic Diseases</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<criteria>Eligible patient 50 80yearold men experience follow urinary symptom least 6 month : frequent urgent need urinate difficulty start urinary stream interruption urinary stream feel incomplete empty bladder urinate interruption sleep due urge urinate Patients tried oral medication condition past , willing discontinue current BPH medication period time undergo study treatment . They good general health previous surgery , procedure ( ) intend reduce prostate size .</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2004</verification_date>
	<keyword>Prostate</keyword>
	<keyword>BPH</keyword>
	<keyword>Prostatitis</keyword>
</DOC>